Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2002-5-17
pubmed:abstractText
Acute exacerbations of chronic obstructive pulmonary disease (COPD) are managed with increased doses or frequency of the patient's existing bronchodilator therapy. The use of formoterol in the treatment of mild acute exacerbations of COPD has been suggested; however, a comparison of cumulative doses of formoterol with salbutamol, the gold standard bronchodilator agent for this pathologic condition, is still lacking.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
0149-2918
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
595-604
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12017404-Administration, Inhalation, pubmed-meshheading:12017404-Aged, pubmed-meshheading:12017404-Albuterol, pubmed-meshheading:12017404-Bronchodilator Agents, pubmed-meshheading:12017404-Cross-Over Studies, pubmed-meshheading:12017404-Dose-Response Relationship, Drug, pubmed-meshheading:12017404-Ethanolamines, pubmed-meshheading:12017404-Female, pubmed-meshheading:12017404-Forced Expiratory Volume, pubmed-meshheading:12017404-Humans, pubmed-meshheading:12017404-Male, pubmed-meshheading:12017404-Middle Aged, pubmed-meshheading:12017404-Nebulizers and Vaporizers, pubmed-meshheading:12017404-Oximetry, pubmed-meshheading:12017404-Oxygen Consumption, pubmed-meshheading:12017404-Powders, pubmed-meshheading:12017404-Pulmonary Disease, Chronic Obstructive, pubmed-meshheading:12017404-Single-Blind Method, pubmed-meshheading:12017404-Smoking, pubmed-meshheading:12017404-Vital Capacity
pubmed:year
2002
pubmed:articleTitle
Formoterol as dry powder oral inhalation compared with salbutamol metered-dose inhaler in acute exacerbations of chronic obstructive pulmonary disease.
pubmed:affiliation
Department of Respiratory Medicine, A. Cardarelli Hospital, Naples, Italy. mcazzola@qubisoft.it
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't